Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010360 · ClinicalTrials.gov registry record
Identification of Celiac Ganglia
A clinical trial of Celiac Ganglia, sponsored by Indiana University.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01010360: Completed study of Celiac Ganglia, sponsored by Indiana University.
NCT01010360 is a study of Celiac Ganglia that has completed, run by Indiana University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01010360, a study of Celiac Ganglia, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Computer-aided image recognition will improve the technique of endoscopic ultrasound-celiac plexus block/celiac plexus neurolysis (EUS-CPB/CPN) and improved pain relief.
Conditions Studied
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-09 |
What the finished NCT01010360 record still lists
NCT01010360 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Celiac Ganglia appearing as the primary indexed condition, and to 0 interventions.
NCT01010360 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT01010360 about?
NCT01010360 is a clinical study titled "Identification of Celiac Ganglia". Computer-aided image recognition will improve the technique of endoscopic ultrasound-celiac plexus block/celiac plexus neurolysis (EUS-CPB/CPN) and improved pain relief.
What is the current status of trial NCT01010360?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-08. Estimated completion is 2012-09.
What conditions does trial NCT01010360 study?
This clinical trial studies the following conditions: Celiac Ganglia.
Who is sponsoring clinical trial NCT01010360?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01010360 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia